Leading the Way: Black Women Closing the Gap in Brain Health

As we celebrate Black History Month and head into Women’s History Month, one thing is clear: progress in Alzheimer’s research has never happened without bold, intentional leadership. And today, some of the most powerful forces reshaping the future of brain health are Black women scientists. Two leaders whose impact stands out are Lisa L. Barnes and Jennifer J. Manly. Their work has transformed the conversation around brain health, particularly in Black communities that face a disproportionately higher risk of developing Alzheimer’s disease yet have historically been underrepresented in research. Dr. Barnes, the Alla V. and Solomon Jesmer Professor of Gerontology

Watch: UsAgainstAlzheimer’s President and United for Cures Executive Director Russ Paulsen on Why Funding Alzheimer’s Research Is Urgent

Last week, our President and COO, Russ Paulsen, joined Punchbowl News founder Anna Palmer for a powerful conversation on the importance of medical research funding in the fight to cure Alzheimer’s and other diseases. Russ also serves as Executive Director of United for Cures, a collaborative network of patient advocacy organizations working together to protect and strengthen federal research funding. Watch the full conversation here: “Cures Matter to Everybody”
 During their conversation, Russ emphasized why medical research funding is one of the few issues that consistently transcends party lines. “If you have a chronic disease, if you have a disease

One Million Visitors and the Power of Early Detection

Reaching one million visitors is more than a milestone for BrainGuide. It is proof that trusted, accessible information can make a real difference in people’s lives. Behind every visit is a person seeking answers about brain health. Someone noticing changes. Someone caring for a loved one. Someone taking a first or next step during a moment of uncertainty. We’re honored to have supported one million people, families, concerned individuals -- and counting -- who turned to BrainGuide for answers. Since its launch in 2021, BrainGuide has supported people in learning about brain health, recognizing when changes may matter, and feeling

Alzheimer’s Awareness Month Blog | 
Fact vs. Fiction: Why Early Detection of Alzheimer’s Matters

Alzheimer’s Awareness Month Blog
Fact vs. Fiction: Why Early Detection of Alzheimer’s Matters This Alzheimer’s Awareness Month brings both reflection and hope. The FDA’s recent approval of the first blood test that can help primary care providers rule out Alzheimer’s marks another step forward in how we understand and detect this disease. 
 This milestone reinforces a critical truth: early detection matters. Alzheimer’s begins years—even decades—before noticeable symptoms appear. The sooner we recognize and understand what’s happening in the brain, the more options people have to take control of their health, plan for the future, and participate in research that can

Centers for Medicare and Medicaid Services: Appropriately cover the costs of blood tests helping to detect Alzheimer’s

UsAgainstAlzheimer’s, along with a coalition of leading advocacy groups, is calling for the Centers for Medicare and Medicaid Services (CMS) to appropriately cover the costs of blood tests helping to detect Alzheimer’s. October 25, 2024 Meena Seshamani, MD, PhD Deputy Administrator and Director, Center for Medicare Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Dr. Seshamani: RE: CY 2025 Clinical Laboratory Fee Schedule Preliminary Determinations: Category 1 CPT®[1] Codes and Assays for Fluid-Based Amyloid Beta and Tau Protein Biomarkers Alzheimer’s disease and related dementias are only diagnosed about half of the time. The pathology is detected